Bicocca Open Archive

Logo unimib boa
SALA, GESSICA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 7.160
EU - Europa 3.871
AS - Asia 1.535
SA - Sud America 37
Continente sconosciuto - Info sul continente non disponibili 10
AF - Africa 6
OC - Oceania 1
Totale 12.620
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 7.039
IT - Italia 908
DE - Germania 693
CN - Cina 574
SE - Svezia 527
SG - Singapore 517
IE - Irlanda 396
RU - Federazione Russa 326
UA - Ucraina 298
GB - Regno Unito 221
HK - Hong Kong 132
AT - Austria 116
CA - Canada 115
FI - Finlandia 102
IN - India 85
FR - Francia 58
PL - Polonia 52
VN - Vietnam 52
DK - Danimarca 47
ID - Indonesia 45
BE - Belgio 42
IR - Iran 39
NL - Olanda 37
BR - Brasile 33
TR - Turchia 31
JP - Giappone 20
KR - Corea 18
CZ - Repubblica Ceca 9
EU - Europa 9
ES - Italia 8
CH - Svizzera 6
GR - Grecia 5
MX - Messico 5
RO - Romania 5
TW - Taiwan 5
LT - Lituania 4
PT - Portogallo 4
EG - Egitto 3
PH - Filippine 3
PK - Pakistan 3
CL - Cile 2
CY - Cipro 2
MU - Mauritius 2
MY - Malesia 2
SA - Arabia Saudita 2
SK - Slovacchia (Repubblica Slovacca) 2
A1 - Anonimo 1
AU - Australia 1
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
BO - Bolivia 1
BZ - Belize 1
CO - Colombia 1
EE - Estonia 1
GA - Gabon 1
HU - Ungheria 1
IL - Israele 1
KG - Kirghizistan 1
KH - Cambogia 1
KZ - Kazakistan 1
LK - Sri Lanka 1
NO - Norvegia 1
Totale 12.620
Salva come PNG Salva come JPEG
Città #
Ann Arbor 1.609
Woodbridge 679
Chandler 545
Houston 482
Frankfurt am Main 476
Singapore 444
Fairfield 392
Ashburn 380
Dublin 380
Jacksonville 343
Wilmington 319
Milan 295
Dearborn 263
Santa Clara 225
New York 210
Seattle 167
Princeton 152
Cambridge 135
Hong Kong 130
Vienna 113
Shanghai 103
Nanjing 90
Boardman 68
Lachine 61
Altamura 53
Lawrence 47
Jakarta 45
Kraków 44
Brussels 41
Beijing 39
Fremont 36
Guangzhou 33
Helsinki 33
Shenyang 31
Pisa 30
Nanchang 27
Dong Ket 26
San Diego 26
Changsha 25
Rome 25
Andover 24
Jinan 23
Falls Church 22
Hebei 22
Tianjin 22
Grafing 21
Munich 21
Pune 21
Monza 20
Jiaxing 19
Lecco 19
London 19
Toronto 19
Turin 19
Ottawa 18
Zhengzhou 18
Dallas 17
Tehran 16
Ningbo 13
Mountain View 12
Norwalk 11
Auburn Hills 10
Como 10
Lissone 10
Los Angeles 10
Cinisello Balsamo 9
Detroit 9
Edmonton 9
Hangzhou 9
Huizen 9
Kunming 9
Bologna 8
Brno 8
Desio 8
Hefei 8
Itaborai 8
Redmond 8
Bari 7
Belo Horizonte 7
Nürnberg 7
Florence 6
Lappeenranta 6
Paderno Dugnano 6
Pioltello 6
Rho 6
San Mateo 6
Zanjan 6
Amsterdam 5
Leawood 5
Monmouth Junction 5
University Park 5
Washington 5
Zurich 5
Cambiago 4
Carate Brianza 4
Chicago 4
Daejeon 4
Falkenstein 4
Kiev 4
Lanzhou 4
Totale 9.281
Salva come PNG Salva come JPEG
Nome #
ALS Cognitive Behavioral Screen (ALS-CBS): normative values for the Italian population and clinical usability 446
NMR-driven identification of anti-amyloidogenic compounds in green and roasted coffee extracts 367
Rotenone down-regulates HSPA8/hsc70 chaperone protein in vitro: A new possible toxic mechanism contributing to Parkinson's disease 311
Oxidative stress and altered mitochondrial dynamics in neurodegenerative processes 279
Serum naturally occurring anti-TDP-43 auto-antibodies are increased in amyotrophic lateral sclerosis 265
Riluzole Selective Antioxidant Effects in Cell Models Expressing Amyotrophic Lateral Sclerosis Endophenotypes 246
NMR-based Lavado cocoa chemical characterization and comparison with fermented cocoa varieties: insights on cocoa’s anti-amyloidogenic activity 245
Ischemic Conditions Affect Rerouting of Tau Protein Levels: Evidences for Alteration in Tau Processing and Secretion in Hippocampal Neurons 241
Reduced platelet glutamate uptake in Parkinson's disease 240
HSC70 expression is reduced in lymphomonocytes of sporadic ALS patients and contributes to TDP-43 accumulation 220
Increased susceptibility to plasma lipid peroxidation in Alzheimer disease patients 207
Rotenone upregulates alpha-synuclein and myocyte enhancer factor 2D independently from lysosomal degradation inhibition 207
Valproate and HDAC inhibition: A new epigenetic strategy to mitigate phenotypic severity in ALS? 206
Rotenone-induced down-regulation of HSPA8/hsc70 protein increases alphasynuclein in vitro: possible implications for Parkinson’s disease 205
Impairment of glutamate transport and increased vulnerability to oxidative stress in neuroblastoma SH-SY5Y cells expressing a Cu,Zn superoxide dismutase typical of familial amyotrophic lateral sclerosis 200
Peripheral cytokine release in Alzheimer patients: Correlation with disease severity 200
In vitro study of autophagy dysfunctions associated with Parkinson’s disease 200
Study of alpha-synuclein and its catabolic pathways in ex vivo cells of patients with Parkinson’s disease 187
Vesicular monoamine transporter 2 mRNA levels are reduced in platelets from patients with Parkinson's disease 185
Leber hereditary optic neuropathy mtDNA mutations disrupt glutamate transport in cybrid cell lines 181
Platelet glutamate uptake as peripheral marker of excitotoxicity in neurodegenerative disorders 181
Glutamate transporters in platelets: EAAT1 decrease in aging and in Alzheimer's disease 175
Rotenone down-regulates hspa8/hsc70 protein in vitro: a new possible toxic mechanism contributing to Parkinson’s disease 172
Reduced expression of the chaperone-mediated autophagy carrier hsc70 protein in lymphomonocytes of patients with Parkinson's disease 172
Alpha-Synuclein, Oxidative Stress and Autophagy Failure: Dangerous Liaisons in Dopaminergic Neurodegeneration 171
AUTOPHAGY ALTERATION UNDER ISCHEMIC CONDITION: A POSSIBLE LINK TO ALZHEIMER'S DISEASE 169
Study Of Chaperone Mediated Autophagy in Lymphomonocytes of sporadic and familial als patients evidenced Hsc70 reduction and TDP-43 aggregation 169
Huntington's disease and HDACi: Would sulpiride and valproate be of therapeutic value? 167
Lack of evidence for oxidative stress in sporadic amyotrophic lateral sclerosis fibroblasts 167
Acute lipophilicity-dependent effect of intravascular simvastatin in the early phase of focal cerebral ischemia 167
A panel of macroautophagy markers in lymphomonocytes of patients with amyotrophic lateral sclerosis 167
Effect of mitochondrial complex I inhibition on chaperone-mediated and myocyte enhancer factor 2D in human neuroblastoma cells 166
Pravastatin acute neuroprotective effects depend on blood brain barrier integrity in experimental cerebral ischemia 166
Decreased platelet glutamate uptake and genetic risk factors in patients with Parkinson's disease 165
Nerve growth factor and transforming growth factor-β serum levels in acute stroke patients: Possible involvement of neurotrophins in cerebrovascular disease 164
Myocyte Enhacer Factor 2 Pathway Disruption in Lymphomonocytes of Patients with Sporadic and Familial Form of Amyotrophic Lateral Sclerosis 163
Riluzole display glutamate-independent antioxidant properties: relevance for ALS 162
Inhibition of retrograde transport modulates misfolded protein accumulation and clearance in motoneuron diseases 156
MEF2D and MEF2C pathways disruption in sporadic and familial ALS patients 154
NMR-driven identification of cinnamon bud and bark components with anti-Aβ activity 153
Ischemic injury elicits the unconventional secretion of protein hallmarks of Alzheimer's disease onset as seeds for interneuronal propagation 152
Common variants in Alzheimer's disease and risk stratification by polygenic risk scores 150
Mitochondrial dysfunction due to mutant copper/zinc superoxide dismutase associated with amyotrophic lateral sclerosis is reversed by N-acetylcysteine 149
Reduced expression of hsc70 protein in lymphomonocytes of patients with Parkinson's disease 149
Exploring the role of autophagy in the pathogenesis of rotenone-induced toxicity 149
Assessment of chaperone-mediated autophagy in circulating lymphomonocytes of patients with Parkinson disease 144
A Preliminary Study of Chaperone-Mediated Autophagy in ALS Lymphomonocytes 144
Partial mitochondrial complex I inhibition induces oxidative damage and perturbs glutamate transport in primary retinal cultures. Relevance to Leber Hereditary Optic Neuropathy (LHON) 141
MEF2C and MEF2D alterations in sporadic and familial ALS patients: a possible correlation with disease progression? 139
Analysis of glutamate transporters in peripheral cells: A tool to invistigate excitotoxicity in neurodegenerative disorders 138
MEF2D and MEF2C Pathways Disruption in Sporadic and Familial ALS Patients 138
Decreased platelet glutamate uptake in patients with amyotrophic lateral sclerosis 134
Myocyte enhancer factor-2D expression in ALS lymphomonocytes 134
Study of alpha-synuclein and its catabolic pathways in lymphomonocytes of patients with Parkinson's disease 132
the MonzALS collaborative network 130
Alzheimer's Disease Prevention through Natural Compounds: Cell-Free, in Vitro, and in Vivo Dissection of Hop (Humulus lupulus L.) Multitarget Activity 129
Role of chaperone-mediated autophagy dysfunctions in the pathogenesis of Parkinson’s disease 129
Macroautophagy is not altered in ALS lymphomonocytes 128
New insights into the genetic etiology of Alzheimer's disease and related dementias 127
Chaperone mediated autophagy in Parkinson's disease: Study in peripheral blood cells from patients and in a cellular model 126
Mef2d-mef2c pathways are altered in lymphomonocytes of patients with sporadic and familial form of amyotrophic lateral sclerosis 126
Direct current stimulation enhances neuronal alpha-synuclein degradation in vitro 126
Increased interleukin-6 release from peripheral blood cells of patients after brain trauma 122
HSPA8 knock-down induces the accumulation of neurodegenerative disorder-associated proteins 118
Myocyte Enhacer Factor 2 Pathway Disruption in Lymphomonocytes of Patients with Sporadic and Familial Form of Amyotrophic Lateral Sclerosis 116
Whole-blood global DNA methylation and phenotypic variability in ALS 114
Assessing glutamatergic function and dysfunction in peripheral tissues 113
Antioxidants partially restore glutamate transport defect in leber hereditary optic neuropathy cybrids 112
Dysfunction of chaperone-mediated autophagy in lymphomonocytes from patients with Parkinson's disease and in a cellular model 112
Digested Cinnamon (Cinnamomum verum J. Presl) Bark Extract Modulates Claudin-2 Gene Expression and Protein Levels under TNFα/IL-1β Inflammatory Stimulus 110
Interactions between excitotoxicity and oxidative stress in ALS: clues for pharmacotherapy 109
Myocyte Enhacer Factor-2 Pathway Is Altered In Amyotrophic Lateral Sclerosis Peripheral Blood Mononuclear Cells 109
Valproate Treatment in an ALS Patient Carrying a c.194G>A Spastin Mutation and SMN2 Homozygous Deletion 107
TSPO Modulates Oligomeric Amyloid-β-Induced Monocyte Chemotaxis: Relevance for Neuroinflammation in Alzheimer's Disease 102
Whole-blood global DNA methylation is increased in amyotrophic lateral sclerosis independently of age of onset 100
Recent advances in the therapy of amyotrophic lateral sclerosis: Focus on excitotoxicity 98
ALS genocopy due to co-existence of spastin mutation and SMN2 deletion? A 12 months open label trial with valproic acid 91
Platelets 79
Author Correction: Direct current stimulation enhances neuronal alpha-synuclein degradation in vitro (Scientific Reports, (2021), 11, 1, (2197), 10.1038/s41598-021-81693-8) 42
Author Correction: Common variants in Alzheimer’s disease and risk stratification by polygenic risk scores (Nature Communications, (2021), 12, 1, (3417), 10.1038/s41467-021-22491-8) 40
Glibenclamide-Loaded Engineered Nanovectors (GNVs) Modulate Autophagy and NLRP3-Inflammasome Activation 38
Neuroprotection and Non-Invasive Brain Stimulation: Facts or Fiction? 33
Totale 13.043
Salva come PNG Salva come JPEG
Categoria #
all - tutte 42.299
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 42.299
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020836 0 0 0 0 0 0 297 122 155 109 119 34
2020/20211.498 86 86 145 182 107 81 134 131 132 173 98 143
2021/20221.120 97 126 109 100 81 113 45 57 50 69 108 165
2022/20232.119 190 615 193 239 163 321 26 117 144 17 50 44
2023/20241.674 81 79 104 88 201 456 239 90 79 14 31 212
2024/20251.430 170 407 276 135 253 185 4 0 0 0 0 0
Totale 13.043